跳至主要内容
临床试验/PACTR202002466895205
PACTR202002466895205招募中2 期

Efficacy and safety of Glucosamine sulfate and chondroitin sulfate combination in the treatment of haemophilic arthropathy: randomized, double-blind, placebo-controlled trial

Faculty of pharmacy university of khartoum0 个研究点目标入组 45 人开始时间: 2020年2月13日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Male

入选标准

  • patients diagnosed as having haemophilia A or B,
  • patients at least 5 years old at the time of enrollment,
  • patients classified as having haemophilc arthropathy in Arnold-Hilgartner scale,
  • no concurrent medical or arthritic conditions that could confound evaluation of the index joint,
  • No other active or severe diseases.

排除标准

  • Patients with bleeding disorders other than haemophilia A and B,
  • Patients less than 5 years old,
  • Patients with severe haemophilic arthropathy classified as class O, or IV in Arnold-Hilgartner scale of haemophilic arthropathy,
  • Patients with positive results in HIV, HB, or HC screening tests.
  • a history of clinically significant trauma or surgery to the joints,
  • Or coexisting disease that could preclude successful completion of the trial.

研究者

发起方
Faculty of pharmacy university of khartoum

相似试验